Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo to Use NCI SBIR Grant to Work with FDA on Cancer and Nutrition Studies

NEW YORK (GenomeWeb News) – GeneGo said today that it has received a grant of an undisclosed sum from the National Cancer Institute that it will use to work with the US Food and Drug Administration to develop technology for studying nutrition and cancer causes and prevention.
The company said it will use the one-year Phase I Small Business Innovation Research grant to collaborate with Jim Kaput, director of FDA’s Personalized Nutrition and Medicine program.
The GeneGo program will include a manually curated nutrition database, an ‘omics data repository, and advanced search and statistical modeling technology.
"For the last 60 years, it has been well established that cancer and nutrition are intrinsically connected," but that knowledge has been scattered across “thousands of sources” and is hard to find, GeneGo CEO Yuri Nikolsky said in a statement. “We will assemble the first specialized database on the topic and develop automated tools for data analysis.”

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.